These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies. Maron BJ; Rowin EJ; Casey SA; Link MS; Lesser JR; Chan RH; Garberich RF; Udelson JE; Maron MS J Am Coll Cardiol; 2015 May; 65(18):1915-28. PubMed ID: 25953744 [TBL] [Abstract][Full Text] [Related]
7. Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy. Maron MS; Rowin EJ; Olivotto I; Casey SA; Arretini A; Tomberli B; Garberich RF; Link MS; Chan RHM; Lesser JR; Maron BJ J Am Coll Cardiol; 2016 Mar; 67(12):1399-1409. PubMed ID: 27012399 [TBL] [Abstract][Full Text] [Related]
8. Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes. Desai MY; Bhonsale A; Patel P; Naji P; Smedira NG; Thamilarasan M; Lytle BW; Lever HM JACC Cardiovasc Imaging; 2014 Jan; 7(1):26-36. PubMed ID: 24290569 [TBL] [Abstract][Full Text] [Related]
9. Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy. Maron BJ; Maron MS Heart Rhythm; 2016 May; 13(5):1155-1165. PubMed ID: 26749314 [TBL] [Abstract][Full Text] [Related]
11. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators. Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970 [TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience. Maeda R; Minami Y; Haruki S; Kanbayashi K; Itani R; Suzuki A; Ejima K; Shiga T; Shoda M; Hagiwara N Int J Cardiol; 2016 Jul; 214():419-22. PubMed ID: 27088403 [TBL] [Abstract][Full Text] [Related]
13. Clinical Spectrum and Management of Heart Failure in Hypertrophic Cardiomyopathy. Maron BJ; Rowin EJ; Udelson JE; Maron MS JACC Heart Fail; 2018 May; 6(5):353-363. PubMed ID: 29655822 [TBL] [Abstract][Full Text] [Related]
14. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy. Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967 [TBL] [Abstract][Full Text] [Related]
15. Sudden death related cardiomyopathies - Hypertrophic cardiomyopathy. Goff ZD; Calkins H Prog Cardiovasc Dis; 2019; 62(3):212-216. PubMed ID: 31004609 [TBL] [Abstract][Full Text] [Related]
16. Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction. Rowin EJ; Maron BJ; Carrick RT; Patel PP; Koethe B; Wells S; Maron MS J Am Coll Cardiol; 2020 Jun; 75(24):3033-3043. PubMed ID: 32553256 [TBL] [Abstract][Full Text] [Related]
17. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy. Maron BJ; Maron MS; Wigle ED; Braunwald E J Am Coll Cardiol; 2009 Jul; 54(3):191-200. PubMed ID: 19589431 [TBL] [Abstract][Full Text] [Related]
18. Septal myectomy for obstructive hypertrophic cardiomyopathy in pediatric patients: early and late results. Minakata K; Dearani JA; O'Leary PW; Danielson GK Ann Thorac Surg; 2005 Oct; 80(4):1424-9; discussion 1429-30. PubMed ID: 16181882 [TBL] [Abstract][Full Text] [Related]
19. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294 [TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy. Sedehi D; Finocchiaro G; Tibayan Y; Chi J; Pavlovic A; Kim YM; Tibayan FA; Reitz BA; Robbins RC; Woo J; Ha R; Lee DP; Ashley EA J Cardiol; 2015 Jul; 66(1):57-62. PubMed ID: 25238885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]